DDInter631 DDInter1654
Eltrombopag is used to treat low blood platelet counts in adults with chronic immune (idiopathic) thrombocytopenia (ITP), when certain other medicines, or surgery to remove the spleen, have not worked well enough. ITP is a condition that may cause unusual bruising or bleeding due to an abnormally low number of platelets in the blood. Eltrombopag has also been recently approved (late 2012) for the treatment of thrombocytopenia (low blood platelet counts) in patients with chronic hepatitis C to allow them to initiate and maintain interferon-based therapy.
Selenium is a trace metal in the human body particularly important as a component of glutathione peroxidase, an important enzyme in the prevention of cellular damage by free radicals and reactive oxygen species [FDA Label]
Eltrombopag {u} (Compound) binds {v} (Gene) CYP2C8
Eltrombopag {u} (Compound) is included by {v} (Pharmacologic Class) Thrombopoietin Receptor Agonists
Eltrombopag {u} may cause a minor interaction that can limit clinical effects when taken with {v} Boceprevir
Eltrombopag {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Idelalisib
Eltrombopag {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Simvastatin
Eltrombopag {u} may lead to a major life threatening interaction when taken with {v} Berotralstat
Eltrombopag {u} may lead to a major life threatening interaction when taken with {v} Peginterferon alfa-2b
Eltrombopag (Compound) binds CYP2C8 (Gene)
Eltrombopag (Compound) is included by Thrombopoietin Receptor Agonists (Pharmacologic Class)
Eltrombopag may cause a minor interaction that can limit clinical effects when taken with Boceprevir
Eltrombopag may cause a moderate interaction that could exacerbate diseases when taken with Idelalisib
Eltrombopag may cause a moderate interaction that could exacerbate diseases when taken with Simvastatin
Eltrombopag may lead to a major life threatening interaction when taken with Berotralstat
Eltrombopag may lead to a major life threatening interaction when taken with Peginterferon alfa-2b